The batch of Napa syrup, which has been at the centre of controversy after the death of two children in Ashuganj, was found safe and standard, said officials of Director General of Drug Administration (DGDA) on Monday.

The DGDA collected samples of the syrup, a product of Beximco Pharmaceuticals, from the shop, from where the medicine was purchased.  After testing eight samples of the three batches the unvestigators found the quality of the medicine accurate, said the DGDA source.

DGDA Director General Major General Mohammad Yousuf said this  at a press briefing held at its office. 

All the reports of eight bottles came out positive and no harmful substance was found in the tested samples, he said.

Replying to a question, whether the medicine was fake, Yousuf, said the used bottle of syrup is  with the Criminal Investigation Department (CID) and the actual reason behind the deaths of two children will be known after getting forensic report.

READ: Napa syrup deaths in B’baria: DGDA sends samples for testing

Already two probe bodies have been formed in this connection while samples of the syrups of the same batch have been collected and sent for testing, he added.

On Thursday night, two siblings named Yasin Khan,7, and Morsalin Khan,5, son of Ismail Khan, a brick kiln worker, died after given Napa syrup at their home for high fever.

It was bought from a local ‘Ma Pharmacy’ owned by Main Uddin and the syrup had an expiry date mentioned till 2023.

The children were discharged after being given primary medications at District Sadar Hospital. Yasin died on the way home, and Morsalin after reaching home, the family said.